Kassandra Lepack;Weijiang Zhang;Eric L. Stangeland;Sheila Zipfel;Daniel D. Long;Gavin Ogawa;Lan Jiang;Daisuke Roland Saito;Xiaojun Huang;Robert Murray McKinnell;Lori Jean Van Orden;Mandy Loo
发明人:
Robert Murray McKinnell,Daniel D. Long,Lori Jean Van Orden,Lan Jiang,Mandy Loo,Daisuke Roland Saito,Sheila Zipfel,Eric L. Stangeland,Kassandra Lepack,Gavin Ogawa,Xiaojun Huang,Weijiang Zhang
申请号：
US13288216
公开号：
US08921372B2
申请日:
2011.11.03
申请国别(地区):
US
年份:
2014
代理人:
摘要：
The invention provides compounds of formula (I):wherein the variables are defined in the specification, or a pharmaceutically-acceptable salt thereof, that are inhibitors of replication of the hepatitis C virus. The invention also provides pharmaceutical compositions comprising such compounds, methods of using such compounds to treat hepatitis C viral infections, and processes and intermediates useful for preparing such compounds.
